Next Article in Journal
Phytochemical Profile and Biological Activities of Satureja hortensis L.: A Review of the Last Decade
Previous Article in Journal
Comparative Study of Volatile Compounds in the Fruit of Two Banana Cultivars at Different Ripening Stages
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 23
Issue 10
10.3390/molecules23102457
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Antifungal Activities and Molecular Docking Studies of Benzoxazole and Benzothiazole Derivatives

by
Bo Luo
1,2,
Ding Li
2,*,
An-Ling Zhang
2 and
Jin-Ming Gao
2,*
1
College of Life Sciences, Xinyang Normal University, Tea Plant Biology Key Laboratory of Henan Province, Xinyang 464000, China
2
Shaanxi Key Labotory of Natural Products & Chemical Biology, Shaanxi Engineering Center of Bioresource Chemistry & Sustainable Utilization, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, China
*
Authors to whom correspondence should be addressed.
Molecules 2018, 23(10), 2457; https://doi.org/10.3390/molecules23102457
Submission received: 21 August 2018 / Revised: 14 September 2018 / Accepted: 19 September 2018 / Published: 25 September 2018
Browse Figures
Versions Notes

Abstract

:
Based on benzoxazole and benzothiazole scaffold as an important pharmacophore, two series of 2-(aryloxymethyl) benzoxazole and benzothiazole derivatives were synthesized and their antifungal effects against eight phytopathogenic fungi were evaluated. Compounds 5a, 5b, 5h, and 5i exhibited significant antifungal activities against most of the pathogens tested. Especially 5a, 5b, 5h, 5i, 5j, and 6h inhibited the growth of F. solani with IC50 of 4.34–17.61 μg/mL, which were stronger than that of the positive control, hymexazol (IC50 of 38.92 μg/mL). 5h was the most potent inhibitor (IC50 of 4.34 μg/mL) against F. Solani, which was about nine times more potent than hymexazol. Most of the test compounds displayed significant antifungal effects against B. cinerea (IC50 of 19.92–77.41 μg/mL), among them, 5a was the best one (IC50 of 19.92 μg/mL). The structure-activity relationships (SARs) were compared and analyzed. The result indicates that the electron-drawing ability and position of the substituents have a significant impact on biological activities. Furthermore, docking studies were carried out on the lipid transfer protein sec14p from S. cerevisiae, and preliminarily verified the antifungal activities. Taken together, these results provide 2-(phenoxymethyl)benzo[d]oxazole as an encouraging framework that could lead to the development of potent novel antifungal agents.

Graphical Abstract

1. Introduction

Plant diseases lead to serious losses to agriculture worldwide and pose an emerging threat to the global food security [1]. Especially, phytopathogenic fungi, which are extremely difficult to manage in agricultural production, have caused the most serious problems, accounting for 70–80% of plant diseases. Several important fungal plant pathogens, such as the genera Colletotrichum, Botrytis, Alternaria, and Fusarium have attracted great attention due to their typical infected disease symptoms (e.g., anthracnose caused by Colletotrichum species characterized by sunken necrotic lesions usually surrounded by a red margin) [2]. Chemical treatments have shown promising prospect in the control of the disease [3]. However, the chemicals have also led to fungicide resistance and environmental pollution, which may pose a serious risk to animal and human health [4]. Therefore, there is an increasing need for more safe and environment friendly antifungal agents to effectively control these plant diseases.
The benzoxazole and benzothiazole scaffolds are found in various synthetic drugs displaying a broad-spectrum biological activities including antiparasitic, antibacterial, antiviral, cytotoxic, and herbicidal properties [5,6,7]. Thus they usually act as the important guide frame and parent skeleton, playing very important roles in medicinal chemistry and agrochemicals. For example, they can emerge as medicament because of their anti-inflammatory, antimalarial, and antitumor properties [8,9,10]. What is more, they often have such advantage as good selectivity, high activity and are eco-friendly compared with pesticides. Chemical structures of some drugs bearing benzoxazole and benzothiazole scaffolds are showed in Figure 1.
However, to the best of our knowledge, few reports [11,12] on fungicidal activity of benzoxazole and benzothiazole derivatives against plant pathogenic fungi have been published. The chemical structures of these antifungal compounds were showed in Figure 2. Thus, it is of great significance to design and synthesize antifungal compounds bearing benzoxazole and benzothiazole scaffolds.
In our previous studies, benzimidazole derivatives and alkyl or benzyl acetophenone ether derivatives were synthesized, and some compounds showed promising fungicidal activities to plant pathogens [13,14]. In continuation of our investigation on antifungal compounds, two series of benzoxazole and benzothiazole derivatives were designed and synthesized from intermediates 2-chloromethyl-benzoxazole and 2-chloromethyl-benzothiazole through etherification reaction (Scheme 1), their structures were characterized by 1H and 13C-NMR spectroscopy and mass spectroscopy (MS). Their fungicidal activities against eight agricultural phytopathogenic fungi were evaluated by the mycelium growth rate method, and the structure-activity relationships of these derivatives were also discussed.

2. Results and Discussion

2.1. Chemistry

The synthetic pathways for the preparation of the target products 5a–m and 6a–m are shown in Scheme 1. In general, intermediate 2-chloromethyl-benzoxazole 3 can be commonly obtained by condensation of 2-aminophenol with chloroacetyl chloride [15,16] or chloroacetic acid [17]. We tried to adapt the methods reported, but the yield was unsatisfactory. In addition, both methods used polyphosphoric acid (PPA) as a reactant, which not only caused difficulty in aftertreatment but was also unfriendly to the environment [18,19]. In order to overcome these disadvantages, we reacted 2-aminophenol with ethyl chloroacetimidate hydrochloride in methylene chloride at 0 °C to provide the compound 3 with 86.5% yield according to the method described by Sheng [20].
Similarly, 2-chloromethyl-benzothiazole 4 can also be obtained from the condensation of 2-aminothiophenols with chloroacetyl chloride [21,22,23], chloroacetic acid [24,25,26], or chloroacetonitrile [9]. Firstly, we tried to prepare 4 according to these literatures, but the yield was not ideal. Then we employed a microwave-assisted procedure developed by Gellis [27], treating 2-aminobenzenethiol 2 with 2-chloroacetyl chloride in acetic acid under microwave irradiation for 10 min to provide the required intermediate 4, to our delight, the yield was up to 87%. Compared with the traditional method, the microwave-assisted procedure was environmentally friendly and efficient, with a less time and higher yield. Furthermore, we also tried to prepare 3 by exploiting the microwave-assisted method, but it did not work. At last, Williamson reaction of 3 or 4 with different substituted phenols in dry acetone in the presence of anhydrous K2CO3 at reflux gave the desired compounds 5a–m or 6a–m.
The structures of the synthetic compounds and key intermediates were confirmed by 1H-NMR, 13C-NMR and MS, as well as HRMS (High Resolution Mass Spectrum). Out of the 26 synthesized derivatives, 10 compounds (5d, 5f–i, 5k, 5m, 6g, 6k, and 6m) were novel.

2.2. Antifungal Activity and Structure-Activity Relationships

All the 2-(aryloxymethyl) benzoxazole and benzothiazole derivatives (5a–m, 6a–m) obtained were screened for their preliminary antifungal activity in vitro. Their activities were evaluated on eight different phytopathogenic fungi: Fusarium oxysporum f. sp. niveum, Fusarium. graminearum, Fusarium. solani, Alternaria solani, Colletotrichum gloeosporioides, Valsa mali, Magnaporthe oryzae, and Botrytis cinerea (Table 1).
The initial results showed in Table 1 indicated that some of these synthetic compounds presented significant antifungal effects. These results encouraged us to continue our investigations into further evaluation of their antifungal effects according to the inhibition rates over 60% that were determined for IC50 values (Table 2).
Compounds (5a, 5b, 5c, 5f, 5g, 5h, 5i, 5j, 5m, 6a, 6c, 6h, and 6l) displayed varying degrees of antifungal activities against several plant pathogenic fungi tested, while the other compounds showed lower activities, compared with the positive control hymexazol.

2.2.1. Antifungal Activity of the Benzoxazole Derivatives

As shown in Table 2, of the test benzoxazole derivatives, compound 5a with a non-substituted phenyl ring B exhibited a broad spectrum of biological activity on all of the eight species of plant pathogens (IC50 of 12.27–65.25 μg/mL). 5b with a fluorine group had good antifungal activities against F. Solani, A. solani, C. gloeosporioides, M. oryzae, and B. cinerea, showing IC50 values in the range of 15.98 to 32.78 μg/mL. However, 5c only effected to B. Cinerea (IC50 of 50.04 μg/mL). Notably, the order of antifungal activity of 5a, 5b, and 5c against most of the eight plant pathogens was 5a > 5b > 5c. The results suggested that the introduction of a chlorine or a fluorine atom into the phenyl ring of 5a decreased antifungal activity and the introduction of F into 5a produced higher broad-spectrum antifungal properties than that of Cl. In general, introduction of halogens such as chlorine or fluorine atom into pesticides can enhance activity. But our results were diametric. We supposed one reason was that introducing the electron-withdrawing group on the benzene ring will change the extension direction of the benzene ring, thus weakening the van der Waals interactions with residues Ser201, Gln202, Try205, Pro205, Arg208, and Met209.
Inhibitory activity of 5f and 5g, possessing an aliphatic formate group (e.g., –CO2C2H5), against B. cinerea was almost similar, with IC50 values of 73.04 and 77.41 μg/mL, respectively, but were inactive against the other fungi tested, indicating the aliphatic formate on the p-position of B-ring of benzoxazole derivatives is detrimental to activity.
In addition, the order of antifungal activity of 5h, 5i, and 5j, which all carried a COMe group, against F. solani was 5h > 5j > 5i, with their IC50 data of 4.34, 16.53 and 17.61 μg/mL, respectively, which were all better than the control (IC50 of 38.92 μg/mL), indicating 5h to be the most active compound. In comparison to the other pathogenic organisms tested, 5h and 5i produced more broad-spectrum antifungal properties than that of 5j. These observations suggested that the acetyl group on o-position and m-position of acetophenones of benzoxazoles is better than p-position in antifungal activity.

2.2.2. Antifungal Activity of the Benzothiazole Derivatives

Most of the test benzothiazole derivatives exerted weak antifungal activity (Table 1 and Table 2). However, among the test compounds 6a, 6c, 6h, and 6l, compound 6h, containing an electron-withdrawing acetyl group on the 2-position of the phenyl ring, significantly inhibited the mycelial growth of of F. graminearum, F. Solani and C. gloeosporioides, with IC50 values of 23.39, 15.55 and 29.61 μg/mL, respectively, but were essentially inactive against the other five fungi (Table 2). Additionally, 6a, 6c, and 6l elicited selective and moderate inhibitory effects against B. cinerea, with IC50 values of 62.62, 61.20, and 50.42 μg/mL, respectively, while being almost inactive to the other organisms tested.
On the other hand, most of the test compounds exhibited moderate to strong inhibitory effects on F. solani (IC50 of 4.34–17.61 μg/mL) and B. cinerea (IC50 of 19.92–77.41 μg/mL), implying that they are more sensitive to F. solani and B. cinerea than the other six organisms. Interestingly, between the two species of the genus Fusarium tested, F. solani is more sensitive.
Comparing the antifungal activity of benzoxazole derivatives with benzothiazole derivatives, antifungal effects of most of benzoxazole derivatives were better than those of benzothiazoles, showing that the benzoxazole derivatives may have a more promising future as fungicides. For example, Compound 5a was three-fold more active than the corresponding 6a in antifungal potency against B. cinerea (IC50 of 19.92 and 62.62 μg/mL respectively). The structure activity relationship of the synthesized compounds is shown in Figure 3.

2.3. Molecular Docking Studies

Molecular docking is a fast and efficient computational method to predict the bioactive compounds to a specific protein or reversely predict the target proteins for one bioactive compound [28]. The significant experimental antifungal activities of compounds 5a, 5b, 5h, 5i, 5j, and 6h provide a hint to performing molecular docking studies to identify the potential target. On the one hand, reverse docking was applied to predict the probable targets of the title compounds from antifungal drug proteins, such as sterol 14-alpha demethylase, squalene epoxidase, chitin synthase, fattyacid synthase, N-myristoyltransferase, and tubulin, etc. On the other hand, after reviewing the different chemical classes that docked into the Sec14p active site, such as nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs), picolinamide, and benzamide chemotypes, we examined our compounds on the active site because some structural similarities exist. The results showed that lipid transfer protein Sec14p might be a potential target for our compounds. Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production and are discriminating portals for interrogating phosphoinositide signaling [29]. Sec14p, the major PITP, executes essential functions in several pathogenic fungi and it is required for the efficient secretion of pathogenicity factors. It is an attractive antifungal target as it has been shown to be druggable [30,31].
The picolinamide (PIA) and the benzamide (BEA), reported by professor Hoepfner, are two antifungal compounds with IC50 values of 28.5 and 6.6 μM against S. cerevisiae, respectively. To test this hypothesis, PIA and BEA, as the reference inhibitors, were also docked into the lipid binding pocket of Sec14p. In the resulting docking model, the binding pose of PIA was almost identical to the crystallographic one (PDB 6F0E) (Figure 4A). The binding energy of PIA and BEA were −6.96 and −7.54 kcal/mol, and the inhibit constants were predicted to be 7.97 and 2.99 μM, respectively, which were similar to the experimental in vitro data (Table 3). All these results showed the docking protocols were appropriate and feasible. As shown in Figure 4, the six-test compound shared very similar binding modes with comparable binding affinities (Table 3). The benzoxazole and benzothiazole ring pointed toward the core of the cavity and engaged in a π–π stacking interaction with Tyr151. The phenoxyl ether moieties were oriented toward solvent and made van der Waals interactions with residues Ser201, Gln202, Try205, Pro205, Arg208, and Met209. A hydrogen-bond (H-bond) interaction between the carboxyl of Ser173 and the heteroatom in the benzoxazole ring of the compound 5b (or 5i/5j) could be observed. The binding models of 5h, 5i, and 5j outlines that the acetyl group on the p-position of acetophenones of benzoxazoles destabilized the π–π stacking interaction between the benzoxazole ring with Tyr151 and would be deleterious for ligand binding. Additionally, the number of binding energy (or inhibit constant) for benzoxazole and benzothiazole derivatives with Sec14p, and that for PIA and BEA, it was in the same order of magnitude, which may be one reason for these compounds with different molecular skeleton having similar fungicidal activity.

3. Materials and Methods

3.1. Chemistry

All of the commercial solvents and reagents were of reagent grade. The melting points of test compounds were measured on an X-4 apparatus (Beijing Tech Instrument Co., Beijing, China) and uncorrected. 1H-NMR and 13C-NMR spectra were recorded on a Bruker Avance III 500 MHz spectrometer (Bruker Bios pin, Rheinstetten, Germany) with in CDCl3 with tetramethylsilane (TMS) as internal reference. High-resolution electrospray ionization mass spectrometry (HRESIMS) data were recorded on LCMS-IT-TOF (Shimadzu, Kyoto, Japan). Thin-layer chromatography (TLC) was performed on silica gel 60 F254 (Qingdao Marine Chemical Ltd., Qingdao, China). Column chromatography (CC) was performed over silica gel (200−300 mesh, Qingdao Marine Chemical Ltd., Qingdao, China).

3.1.1. General Experimental Procedures

Synthesis of ethyl chloroacetimidate hydrochloride. A solution of chloroacetonitrile (10.0 g, 133 mmol), ethanol (6.8 g, 148 mmol), and dry ether (76 mL) was stirred and cooled at 0 °C while a stream of dry HCl gas was bubbled through. After 0.5 h, the white crystalline salt had precipitated. Excess dry ether was added to the mixture, which was then filtered, washed with dry ether, and stored over P2O5 in vacuo, leading to ethyl chloroacetimidate hydrochloride as a white solid (16 g, yield 77.6%) [14]. m.p., 89–91 °C.
Synthesis of 2-Chloromethyl-benzoxazole (3) [20]. To a solution of 2-aminophenol (3.76 g, 34.5 mmol) in methylene chloride at 0 °C was added ethyl chloroacetimidate hydrochloride (7.98 g, 50.5 mmol). After 85 min, the reaction mixture was allowed to warm to room temperature, while being stirred overnight. The mixture was filtered over diatomite and concentrated to oil under reduced pressure. The resulting residue was purified by column chromatography on silica gel (petroleum ether/acetone, 10:1 v:v) to obtain compound 3 as a white solid (5.00 g, 86.5%). m.p., 152–154 °C; MS (+ESI) m/z 168.05 [M + H]+.
Synthesis of 2-Chloromethyl-benzothiazole (4) [27]. To a solution of 2-aminobenzenethiol (1 g, 7.93 mmol) in acetic acid (15 mL), and 2-chloroacetyl chloride (1.35 g, 1.19 mmol) was added dropwise. The reaction mixture was irradiated in a microwave oven (Ethos start) for 10 min at a power of 500 W. After cooling, the mixture was poured onto crushed ice (100 mL) and basified with 5 mol/L NaOH. The solution was extracted with chloroform (3 × 50 mL). The combined organic layers were dried over MgSO4 and concentrated under vacuum. Purification of the residue by column chromatography on silica gel (petroleum ether/acetone, 10:1 v:v) gave compound 4 as a yellow solid (1.90 g, 86.8%) [27]. m.p., 89–90 °C; MS (+ESI) m/z 184.02 [M + H]+.

3.1.2. General Procedure for the Synthesis of the Benzoxazole and Benzothiazole Derivatives (5a–m, 6a–m)

To a solution of various substituted phenols (1 mmol) in dry acetone (30 mL) K2CO3 (1 mmol) and compound 3 or 4 (1 mmol) were added. After being stirred for 4 h at reflux temperature, the reaction mixture was cooled, filtered, and concentrated under vacuum. Then the residue was diluted with 30 mL ethyl acetate and sequentially washed with 30 mL 1 M HCl, aq. NaHCO3 solution and brine in order. The organic layer was dried over MgSO4 and concentrated in vacuo. Purification of the residue by chromatography on silica gel furnished target compounds. 1H-NMR, 13C-NMR and mass spectroscopy (MS) of compounds 5a–m and 6a–m are shown in Supplementary Materials.
2-(phenoxymethyl)benzo[d]oxazole (5a): Yellow solid; yield, 75.56%; m.p., 154–156 °C; 1H-NMR (500 MHz, CDCl3) δ 7.76 (m, 1H, ArH), 7.56 (d, J = 6.9 Hz, 1H, ArH), 7.37 (m, 2H, ArH × 2), 7.32 (t, J = 7.7 Hz, 2H, ArH × 2), 7.07 (d, J = 8.4 Hz, 2H, ArH × 2), 7.02 (t, J = 7.3 Hz, 1H, ArH), 5.33 (s, 2H, CH2); and ESI-MS m/z: 225.94 ([M + H]+), 247.92 ([M + Na]+).
2-((4-fluorophenoxy)methyl)benzo[d]oxazole (5b): Yellow solid; yield, 83.13%; m.p., 62–63 °C; 1H-NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 5.9, 2.5 Hz, 1H, ArH), 7.55 (m, 1H, ArH), 7.36 (dd, J = 5.7, 2.3 Hz, 2H, ArH × 2), 7.13–6.92 (m, 4H, ArH × 4), 5.28 (s, 2H, –CH2–O–); and ESI-MS m/z: 244.07 ([M + H]+).
2-((4-chlorophenoxy)methyl)benzo[d]oxazole (5c): Yellow solid; yield, 82.31%; m.p., 85–86 °C; 1H-NMR (500 MHz, CDCl3) δ 7. 74 (m, 1H, ArH), 7.53 (dd, J = 7.3, 1.1 Hz, 1H, ArH), 7.35 (m, 2H, ArH × 2), 7.22 (d, J = 9.0 Hz, 2H, ArH × 2), 6.96 (d, J = 8.9 Hz, 2H, ArH × 2), 5.27 (s, 2H, –CH2–O–); and ESI-MS m/z: 259.84 ([M + H]+), 281.85 ([M + Na]+).
4-(benzo[d]oxazol-2-ylmethoxy)benzaldehyde (5d): White solid; yield, 34%; m.p., 138–140 °C; 1HNMR (500 MHz, CDCl3) δ 9.89 (d, J = 12.2 Hz, 1H, –CHO), 7.86 (dd, J = 9.4, 2.5 Hz, 2H, ArH × 2), 7.77 (m, 1H, ArH), 7.56 (d, J = 7.3 Hz, 1H, ArH), 7.38 (m, 2H, ArH × 2), 7.18 (d, J = 8.7 Hz, 2H, ArH × 2), 5.41 (d, J = 7.2 Hz, 2H, CH2); 13C NMR (125 MHz, CDCl3) δ 190.9 (C=O), 162.8 (–N=C–O–), 160.7 (ArC), 151.2 (ArC), 140.7 (ArC), 132.3 (ArC), 131.2 (ArC), 126.2 (ArC), 125.1 (ArC), 120.7 (ArC), 115.4 (ArC), 111.2 (ArC), 63.0 (–CH2O–); HR-MS (ESI): m/z calcd. for C15H11NO3: 254.0812; found: 254.0785 [M + H]+.
methyl 4-(benzo[d]oxazol-2-ylmethoxy)benzoate (5e): White solid; yield, 67.14%; m.p., 97–99 °C; 1H-NMR (500 MHz, CDCl3) δ 8.01 (dd, J = 11.5, 4.5 Hz, 2H, ArH × 2), 7.77 (m, 1H, ArH), 7.56 (d, J = 7.2 Hz, 1H, ArH), 7.37 (m, 2H, ArH × 2), 7.08 (dd, J = 11.5, 4.5 Hz, 2H, ArH × 2), 5.37 (d, J = 9.1 Hz, 2H, CH2), 3.87 (d, J = 8.8 Hz, 3H, CH3); ESI-MS m/z: 284.37 ([M + H]+), 306.81 ([M + Na]+).
ethyl 4-(benzo[d]oxazol-2-ylmethoxy)benzoate (5f): Yellow solid; yield, 67.34%; m.p., 70–72 °C; 1H-NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.7 Hz, 2H, ArH × 2), 7.77 (m, 1H, ArH), 7.55 (m, 1H, ArH), 7.37 (dd, J = 7.4, 3.6 Hz, 2H, ArH × 2), 7.08 (d, J = 8.7 Hz, 2H, ArH × 2), 5.38 (s, 2H, –CH2–O–), 4.34 (d, J = 7.1Hz, 2H, –CH2–CH3), 1.37 (t, J = 7.1 Hz, 3H, CH3); 13C-NMR (125MHz, CDCl3) δ 166.4 (C=O), 161.6 (–N=C–O–), 161.0 (ArC), 151.2 (ArC), 140.7 (ArC), 131.9 (ArC), 126.1 (ArC), 125.1 (ArC), 124.5 (ArC), 120.7 (ArC), 114.6 (ArC), 111.2 (ArC), 63.0 (–CH2–O–), 61.0(–CH2–CH3), 14.6 (CH3); HR-MS (ESI): m/z calcd. for C17H15NO4: 298.1074; and found: 298.1043 [M + H]+.
propyl 4-(benzo[d]oxazol-2-ylmethoxy)benzoate (5g): White solid; yield, 70.42%; m.p., 44–45 °C; 1H-NMR (500 MHz, CDCl3) δ 8.00 (d, J = 8.6 Hz, 2H, ArH × 2), 7.73 (d, J = 6.6 Hz, 1H, ArH), 7.52 (d, J = 7.3 Hz, 1H, ArH), 7.33 (m, 1H, ArH), 7.06 (d, J = 8.6 Hz, 2H, ArH × 2), 5.35 (s, 2H, –CH2–O–), 4.22 (t, J = 6.6 Hz, 2H, –CH2–CH2–CH3), 1.74 (dd, J = 14.1, 7.1 Hz, 2H, –CH2–CH2–CH3), 0.99 (t, J = 7.4 Hz, 3H, CH3); 13C-NMR (125 MHz, CDCl3) δ 166.3 (C=O), 161.5 (–N=C–O–), 160.9 (ArC), 151.1 (ArC), 140.8 (ArC), 131.8 (ArC), 131.7 (ArC), 125.9 (ArC), 124.9 (ArC), 124.8 (ArC), 124.4 (ArC), 120.6 (ArC), 114.5 (ArC), 111.1 (ArC), 66.5 (–CH2–O–), 62.9 (–CH2–CH2–CH3), 22.3 (–CH2–CH2–CH3), 10.6 (CH3); HR-MS (ESI): m/z calcd. for C18H17NO4: 312.1230; and found: 312.1204 [M + H]+.
1-(2-(benzo[d]oxazol-2-ylmethoxy)phenyl)ethanone (5h): Red solid; yield, 65.17%; m.p., 98–100 °C; 1H-NMR (500 MHz, CDCl3) δ 7.76 (m, 2H, ArH × 2), 7.57 (m, 1H, ArH), 7.47 (t, J = 7.8 Hz, 1H, ArH), 7.38 (m, 2H, ArH × 2), 7.14 (d, J = 8.3 Hz, 1H, ArH), 7.07 (t, J = 7.5 Hz, 1H, ArH), 5.44 (s, 2H, CH2), 2.68 (s, 3H, –COCH3); 13C NMR (125 MHz, CDCl3) δ 199.7 (C=O), 161.0 (–N=C–O–), 157.2 (ArC), 151.2 (ArC), 140.7 (ArC), 133.9 (ArC), 130.9 (ArC), 129.3 (ArC), 126.2 (ArC), 125.1 (ArC), 122.2 (ArC), 120.7 (ArC), 113.1 (ArC), 111.2 (ArC), 63.4 (CH2), 32.2 (CH3); HR-MS (ESI): m/z calcd. for C16H13NO3: 268.0968; and found: 268.0940 [M + H]+.
1-(3-(benzo[d]oxazol-2-ylmethoxy)phenyl)ethanone (5i): Yellow solid; yield, 82.4%; m.p., 71–72 °C; 1H-NMR (500 MHz, CDCl3) δ 7.74 (m, 1H, ArH), 7.64 (s, 1H, ArH), 7.56 (d, J = 7.6 Hz, 1H, ArH), 7.52 (dd, J = 5.4, 2.9 Hz, 1H, ArH), 7.34 (m, 3H, ArH × 3), 7.24 (s, 1H, ArH), 5.34 (s, 2H, CH2), 2.55 (s, 3H, –COCH3); 13C-NMR (125 MHz, CDCl3) δ 197.3 (C=O), 160.9 (–N=C–O–), 158.0 (ArC), 150.8 (ArC), 140.7 (ArC), 138.6 (ArC), 129.8 (ArC), 125.6 (ArC), 124.6 (ArC), 122.0 (ArC), 120.4 (ArC), 119.9 (ArC), 113.8 (ArC), 110.8 (ArC), 62.8 (CH2), 26.6 (CH3); HR-MS (ESI): m/z calcd. for C16H13NO3: 268.0968; and found: 268.0935 [M + H]+.
1-(4-(benzo[d]oxazol-2-ylmethoxy)phenyl)ethanone (5j): Yellow solid; yield, 49.44%; m.p., 110–112 °C; 1H-NMR (500 MHz, CDCl3) δ 7.90 (d, J = 8.7 Hz, 2H, ArH × 2), 7.72 (m, 1H, ArH), 7.50 (d, J = 6.5 Hz, 1H, ArH), 7.33(m, 2H, ArH × 2), 7.06 (d, J = 8.7 Hz, 2H, ArH × 2), 5.35 (s, 2H, CH2), 2.50 (s, 3H, –COCH3); 13C-NMR (125 MHz, CDCl3) δ 196.7 (C=O), 161.6 (–N=C–O–), 160.8 (ArC), 151.0 (ArC), 140.7 (ArC), 131.5 (ArC), 130.8 (ArC), 125.9 (ArC), 124.9 (ArC), 120.6 (ArC), 114.6 (ArC), 111.1 (ArC), 62.8 (CH2), 26.4 (CH3); HR-MS (ESI): m/z calcd. for C16H13NO3: 268.0968; and found: 268.0942 [M + H]+
1-(4-(benzo[d]oxazol-2-ylmethoxy)-2-hydroxyphenyl)ethanone (5k): White solid; yield, 31.8%; m.p., 98–99 °C; 1H-NMR (500 MHz, CDCl3) δ 7.75 (d, J = 6.3 Hz, 1H, ArH), 7.64 (d, J = 8.7 Hz, 1H, ArH), 7.54 (m, 1H, ArH), 7.36(m, 2H, ArH × 2), 6.58 (d, J = 10.9 Hz, 2H, ArH × 2), 5.33(s, 2H, CH2), 2.53 (s, 3H, –COCH3); 13C-NMR (125 MHz, CDCl3) δ 203.0 (C=O), 165.2 (–N=C–O–), 164.1 (ArC), 160.6 (ArC), 151.1 (ArC), 140.7 (ArC), 132.8 (ArC), 126.1 (ArC), 125.0 (ArC), 120.7 (ArC), 115.0 (ArC), 111.2 (ArC), 107.8 (ArC), 102.3 (ArC), 62.9 (CH2), 26.4 (CH3); HR-MS (ESI): m/z calcd. for C16H13NO4: 284.0917; and found: 284.0888 [M + H]+.
4-(benzo[d]oxazol-2-ylmethoxy)-3-methoxybenzaldehyde (5l): Yellow solid; yield, 66.43%; m.p., 100–102 °C; 1H-NMR (500 MHz, CDCl3) δ 9.82 (s, 1H, –CHO), 7.72 (d, J = 6.5 Hz, 1H, ArH), 7.51 (d, J = 7.1 Hz, 1H, ArH), 7.39 (d, J = 12.1 Hz, 2H, ArH × 2), 7.33 (dd, J = 5.9, 2.7 Hz, 2H, ArH × 2), 7.17 (d, J = 8.1 Hz, 1H, ArH), 5.44 (s, 2H, CH2), 3.90 (s, 3H, CH3); 13C NMR (125 MHz, CDCl3) δ 190.9 (C=O), 160.6 (–N=C–O–), 152.6 (ArC), 151.1 (ArC), 150.3 (ArC), 140.7 (ArC), 131.5 (ArC), 126.4 (ArC), 126.0 (ArC), 124.9 (ArC), 120.6 (ArC), 113.2 (ArC), 111.2 (ArC), 109.9 (ArC), 63.8 (CH2), 56.2 (CH3); and ESI-MS m/z: 284.73 ([M + H]+), 307.03 ([M + Na]+)
2-((4-allyl-2-methoxyphenoxy)methyl)benzo[d]thiazole (5m): Brown liquid; yield, 68%; 1H-NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 94.3, 7.1 Hz, 1H, ArH), 7.35 (m, 1H, ArH), 6.92 (dd, J = 73.5, 8.3 Hz, 1H, ArH), 6.71 (d, J = 28.9 Hz, 2H, ArH × 2), 5.94 (dd, J = 16.2, 10.1, 6.0 Hz, 1H, –CH=CH2), 5.35 (s, 2H, –CH2–O–), 5.07 (d, J = 17.0 Hz, 2H, –CH=CH2), 3.87 (d, J = 2.9 Hz, 3H, CH3), 3.33(d, J = 5.4 Hz, 2H, –CH2CH=CH2); 13C NMR (125MHz, CDCl3) δ 162.0 (–N=C–O–), 151.3 (ArC), 150.1 (ArC), 145.8 (ArC), 141.0 (ArC), 138.1 (ArC), 137.6 (ArC), 135.2 (–CH2CH=CH2), 125.7 (ArC), 124.8 (ArC), 120.6 (ArC), 116.1 (ArC), 115.8 (ArC), 112.7 (–CH2CH=CH2), 111.2 (ArC), 64.7 (–CH2–O–), 56.1 (CH3), 40.1 (–CH2CH=CH2); HR-MS (ESI): m/z calcd. for C18H17NO3: 296.1281; and found: 296.1256 [M + H]+.
2-(phenoxymethyl)benzo[d]thiazole (6a): White solid; yield, 56.02%; m.p., 74–76 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.1 Hz, 1H, ArH), 7.90 (d, J = 8.0 Hz, 1H, ArH), 7.50 (t, J = 7.7 Hz, 1H, ArH), 7.40 (t, J = 7.6 Hz, 1H, ArH), 7.32 (t, J = 7.7 Hz, 2H, ArH × 2), 7.05 (d, J = 8.5 Hz, 2H, ArH × 2), 7.02 (m, 1H, ArH), 5.50 (s, 2H, CH2); and ESI-MS m/z: 241.89 ([M + H]+), 263.87 ([M + Na]+).
2-((4-fluorophenoxy)methyl)benzo[d]thiazole (6b): Yellow solid; yield, 66.41%; m.p., 86–88 °C; 1H-NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.2 Hz, 1H, ArH), 7.90 (d, J = 8.0 Hz, 1H, ArH), 7.50 (dd, J = 11.3, 4.1 Hz, 1H, ArH), 7.41 (dd, J = 11.2, 4.0 Hz, 1H, ArH), 6.98 (d, J = 6.4 Hz, 4H, ArH × 4), 5.46 (s, 2H, -CH2-O-); and ESI-MS m/z: 260.11 ([M + H]+), 282.14 ([M + Na]+).
2-((4-chlorophenoxy)methyl)benzo[d]thiazole (6c): Yellow solid; yield, 79.71%; m.p., 83–86 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.2 Hz, 1H, ArH), 7.88 (d, J = 7.9 Hz, 1H, ArH), 7.50 (dd, J = 11.3, 4.1 Hz, 1H, ArH), 7.41 (t, J = 7.6 Hz, 1H, ArH), 7.23 (d, J = 9.0 Hz, 2H, ArH × 2), 6.93 (d, J = 8.9 Hz, 2H, ArH × 2), 5.43 (s, 2H, –CH2–O–); and ESI-MS m/z: 275.81 ([M]+).
4-(benzo[d]thiazol-2-ylmethoxy)benzaldehyde (6d): Yellow solid; yield, 50.19%; m.p., 106–107 °C; 1H-NMR (500 MHz, CDCl3) δ 9.90 (s, 1H, –CHO), 8.07 (d, J = 8.1 Hz, 1H, ArH), 7.92 (d, J = 8.0 Hz, 1H, ArH), 7.87 (d, J = 8.6 Hz, 2H, ArH × 2), 7.53 (t, J = 7.3 Hz, 1H, ArH), 7.45 (t, J = 7.6 Hz, 1H, ArH), 7.16 (d, J = 8.5 Hz, 2H, ArH × 2), 5.60 (s, 2H, CH2); 13C NMR (125MHz, CDCl3) δ 191.1 (C=O), 167.7 (–N=C–S–), 162.8 (ArC), 152.4 (ArC), 135.0 (ArC), 132.7 (ArC), 132.4 (ArC), 131.2 (ArC), 130.0 (ArC), 126.9 (ArC), 126.0 (ArC), 123.3 (ArC), 122.2 (ArC), 116.3 (ArC), 115.5 (ArC), and 67.9 (CH2). ESI-MS m/z: 270.01 ([M + H]+) and 292.00 ([M + Na]+).
methyl 4-(benzo[d]thiazol-2-ylmethoxy)benzoate (6e): Yellow solid; yield, 25.42%; m.p., 116–118 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.2 Hz, 1H, ArH), 8.01 (s, 1H, ArH), 8.00 (s, 1H, ArH), 7.88 (d, J = 7.9 Hz, 1H, ArH), 7.50 (t, J = 7.5 Hz, 1H, ArH), 7.40 (t, J = 7.4 Hz, 1H, ArH), 7.06 (d, J = 8.3 Hz, 2H, ArH × 2), 5.53 (s, 2H, CH2), 3.87 (s, 3H, CH3); and ESI-MS m/z: 300.68 ([M + H]+), 322.04 ([M + Na]+).
ethyl 4-(benzo[d]thiazol-2-ylmethoxy)benzoate (6f): White solid; yield, 36.42%; m.p., 118–120 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.2 Hz, 1H, ArH), 8.02 (s, 1H, ArH), 8.01 (s, 1H, ArH), 7.89 (d, J = 8.0 Hz, 1H, ArH), 7.50 (t, J = 7.7 Hz, 1H, ArH), 7.41 (t, J = 7.6 Hz, 1H, ArH), 7.05 (d, J = 8.8 Hz, 2H, ArH × 2), 5.54 (s, 2H, –CH2–O–), 4.34 (q, J = 7.1 Hz, 2H, -CH2-CH3), 1.36 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3) δ 167.8(C=O), 166.3 (–N=C–S–), 161.4 (ArC), 152.7 (ArC), 135.1 (ArC), 131.9 (ArC), 126.6 (ArC), 125.7 (ArC), 124.4 (ArC), 123.3 (ArC), 122.1 (ArC), 114.7 (ArC), 67.9 (–CH2–O–), 61.0 (–CH2–CH3), 14.6 (CH3); and ESI-MS m/z: 314.17 ([M + H]+), 336.75 ([M + Na]+).
propyl 4-(benzo[d]thiazol-2-ylmethoxy)benzoate (6g): White solid; yield, 48.93%; m.p., 106–108 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 12.0 Hz, 2H, ArH × 2), 8.01 (s, 1H, ArH), 7.89 (d, J = 8.0 Hz, 1H, ArH), 7.52 (d, J = 7.4 Hz, 1H, ArH), 7.41 (t, J = 7.6 Hz, 1H, ArH), 7.06 (d, J = 8.6 Hz, 2H, ArH × 2), 5.54 (s, 2H, –CH2–O–), 4.25 (t, J = 6.6 Hz, 2H, –CH2–CH2–CH3), 1.77 (dd, J = 14.2, 7.1 Hz, 2H, –CH2–CH2–CH3), 1.01 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3) δ 167.8 (C=O), 166.4 (–N=C–S–), 161.5 (ArC), 152.9 (ArC), 135.2 (ArC), 131.9 (ArC), 126.6 (ArC), 125.7 (ArC), 124.5 (ArC), 123.4 (ArC), 122.1 (ArC), 114.8 (ArC), 68.0 (–CH2–O–), 66.6 (–CH2–CH2–CH3), 22.4 (–CH2–CH2–CH3), 10.7 (CH3); HR-MS (ESI): m/z calcd. for C18H17NO3S: 328.1002; and found: 328.0972 [M + H]+.
1-(2-(benzo[d]thiazol-2-ylmethoxy)phenyl)ethanone (6h): Yellow solid; yield, 80.21%; m.p., 89–90 °C; 1H-NMR (500 MHz, CDCl3) δ 7.91 (m, 1H, ArH), 7.77 (dd, J = 7.6, 1.4 Hz, 1H, ArH), 7.49 (m, 3H, ArH × 3), 7.34(m, 1H, ArH), 7.06 (d, J = 8.7 Hz, 2H, ArH × 2), 5.57 (s, 2H, CH2), 2.74 (s, 3H, –COCH3); and ESI-MS m/z: 284.06 ([M + H]+), 306.10 ([M + Na]+).
1-(3-(benzo[d]thiazol-2-ylmethoxy)phenyl)ethanone (6i): Yellow solid; yield, 67.84%; m.p., 107–108 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.2 Hz, 1H, ArH), 7.90 (d, J = 8.0 Hz, 1H, ArH), 7.65 (s, 1H, ArH), 7.60 (d, J = 7.6 Hz, 1H, ArH), 7.51 (t, J = 7.5 Hz, 1H, ArH), 7.41 (t, J = 7.9 Hz, 2H, ArH × 2), 7.23 (t, J = 6.8Hz,1H, ArH), 5.54 (s, 2H, CH2), 2.60 (s, 3H, –COCH3); HR-MS (ESI): m/z calcd. for C16H13NO2S: 284.0740; and found: 284.0708 [M + H]+.
1-(4-(benzo[d]thiazol-2-ylmethoxy)phenyl)ethanone (6j): White solid; yield, 61.13%; m.p., 148–150 °C; 1H-NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.0 Hz, 1H, ArH), 7.96 (d, J = 8.7 Hz, 2H, ArH × 2), 7.90 (d, J = 8.2 Hz, 1H, ArH), 7.53 (d, J = 7.3 Hz, 1H, ArH), 7.42 (t, J = 7.6 Hz, 1H, ArH), 7.09 (d, J = 8.7 Hz, 2H, ArH × 2), 5.56 (s, 2H, CH2), 2.56 (s, 3H, –COCH3); and ESI-MS m/z: 284.15 ([M + H]+), 306.08 ([M + Na]+).
1-(4-(benzo[d]thiazol-2-ylmethoxy)-2-hydroxyphenyl)ethanone (6k): White solid; yield, 37.46%; m.p., 128–130 °C; 1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.2 Hz, 1H, ArH), 7.91 (d, J = 8.0 Hz, 1H, ArH), 7.68 (s, 1H, ArH), 7.52 (t, J = 7.7 Hz, 1H, ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 6.58 (m, 2H, ArH × 2), 6.40 (d, J = 12.5 Hz, 1H, ArH), 5.53 (s, 2H, CH2), 2.55 (d, J = 9.5 Hz, 3H, –COCH3); 13C NMR (125 MHz, CDCl3) δ 203.1(C=O), 167.6 (–N=C–S–), 165.3 (ArC), 164.1 (ArC), 152.6 (ArC), 133.3 (ArC), 132.9 (ArC), 126.8 (ArC), 125.9 (ArC), 123.3 (ArC), 122.1 (ArC), 115.1 (ArC), 107.8 (ArC), 102.8 (ArC), 67.8 (CH2), 26.5 (CH3); HR-MS (ESI): m/z calcd. for C16H13NO3S: 300.0689; and found: 300.0662 [M + H]+.
4-(benzo[d]thiazol-2-ylmethoxy)-3-methoxybenzaldehyde (6l): Yellow solid; yield, 46.15%; m.p., 110–112 °C; 1H-NMR (500 MHz, CDCl3) δ 9.84 (s, 1H, –CHO), 8.05 (d, J = 8.0 Hz, 1H, ArH), 7.89 (d, J = 7.8 Hz, 1H, ArH), 7.51 (t, J = 7.6 Hz, 1H, ArH), 7.45 (s, 1H, ArH), 7.41 (dd, J = 14.6, 7.7 Hz, 2H, ArH × 2), 7.12 (d, J = 8.0 Hz, 1H, ArH), 5.65 (s, 1H), 3.97 (s, 3H); and ESI-MS m/z: 300.37 ([M + H]+), 322.78 ([M + Na]+).
2-((4-allyl-2-methoxyphenoxy)methyl)benzo[d]oxazole (6m): White solid; yield, 41.8%; m.p., 54–56 °C; 1H-NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.1 Hz, 1H, ArH), 7.88 (d, J = 7.9 Hz, 1H, ArH), 7.49 (m, 1H, ArH), 7.39 (dd, J = 11.2, 4.0 Hz,1H, ArH), 6.95 (d, J = 8.1 Hz, 1H, ArH), 6.77 (s, 1H, ArH), 6.68 (d, J = 8.0 Hz, 1H, ArH × 2), 5.94 (dd, J = 16.9, 10.1 Hz, 1H, –CH=CH2), 5.54 (s, 2H, –CH2–O–), 5.09 (d, J = 1.3 Hz, 1H, –CH=CH2), 5.06 (d, J = 0.9 Hz, 1H, CH=CH2), 3.91 (s, 3H, CH3), 3.33 (d, J = 6.6 Hz, 2H, –CH2CH=CH2); 13C-NMR (125 MHz, CDCl3) δ 169.9 (–N=C–S–), 152.5 (ArC), 150.1 (ArC), 145.9 (ArC), 137.6 (ArC), 135.1 (–CH2CH=CH2), 126.5 (ArC), 125.5 (ArC), 123.1 (ArC), 122.1 (ArC), 120.8 (ArC), 116.1 (ArC), 115.6 (–CH2CH=CH2), 113.0 (ArC), 69.6 (–CH2–O–), 56.2 (CH3), 40.0 (–CH2CH=CH2); HR-MS (ESI): m/z calcd. for C18H17NO2S: 312.1053; and found: 312.1024 [M + H]+.

3.2. Antifungal Bioassay

According to our previous research [32,33,34], the mycelium growth rate method was employed to assess the fungicidal activities of the synthetic compounds against eight plant pathogenic fungi (Fusarium oxysporum f. sp. niveum, Fusarium. graminearum, Fusarium. solani, Alternaria solani, Colletotrichum gloeosporioides, Valsa mali, Magnaporthe oryzae, and Botrytis cinerea), which were provided by the Institute of Plant Disease, Northwest A and F University, China. The strains were retrieved from the storage tube and cultured for two weeks at 28 ± 0.5 °C on a potato dextrose agar (PDA).
The specific methods are based on the literature [1]: PDA medium was prepared in the conical flasks and sterilized. The tested compounds were dissolved in acetone, making five concentrations with the gradients of 100, 50, 25, 12.5, and 6.25 μg/mL, before mixing with molten agar at 55 °C. The mixture was then poured into sterilized Petri dishes. The tested fungi were incubated in PDA at 28 ± 0.5 °C for one week for the antifungal assays. A hole puncher with a diameter of four mm was used to cut culture medium and vaccinated to the center of the PDA Petri dishes with a sterilized inoculation needle. The inoculated Petri dishes were incubated at 28 ± 0.5 °C for three-to-four days until the mycelia grew completely. Commercially available fungicide hymexazol was used as the positive control, while the solution of equal concentration of acetone was used as a negative control. Three repetitions were conducted for each sample and the diameters of the mycelia were measured four times by cross bracketing method. The inhibition rate was calculated according to the formula:
Inhibition rate (%) = (C − T)/(C − 4 mm) × 100%
where C is the average diameter of mycelia in the blank test, and T is the average diameter of mycelia on treated PDA with those compounds.
The inhibition ratio of those compounds at the concentration of 100 μg/mL was shown in Table 1. The compounds with more than 60% inhibition rates were selected for further comparison and IC50 (median inhibitory concentration) values of rates were determined. The experimental data of the fungicidal activities were analyzed using software of excel from Windows to give the results of IC50 values, as shown in Table 2.

3.3. Molecular Docking Studies

The crystal structure the lipid transfer protein sec14p from Saccharomyces cerevisiae (PDB 6F0E) was provided from the Brookhaven protein data bank (PDB; http://www.rcsb.org/pdb). Docking studies were performed by using AutoDock 4.2 software (The Scripps Research Institute, California, CA, USA), as in our previous studies [35]. The preparations relevant to Autodock docking were done using the Autodock Tools. The grid box (40 × 40 × 40) was set according to the active site. The docking parameters consisted of setting the population size to 150, the number of generations to 270,000, and the number of evaluations to 25,000,000 while the number of docking runs was set to 40 with other default values during each docking run. Docking calculations were carried with the Lamarkian Genetic Algorithm (LGA). The analysis of results was carried out by USCF Chimera software (the Computer Graphics Laboratory, California, CA, USA), which was downloaded from http://www.cgl.ucsf.edu/chimera.

4. Conclusions

In the present study, a series of benzoxazole and benzothiazole derivatives were prepared and their fungicidal activities against eight plant pathogens were tested. Most of the test compounds, i.e., 5a, 5b, 5h, and 5i, were found to be more active against two fungi, F. solani and B. cinerea, than the other six organisms. 5a, 5b, 5h, and 5i were found to be most efficient antifungal compounds and may be new leads for the development of new fungicides. Furthermore, from the present results, it appears that benzoxazoles have an advantage over benzothiazoles as a template in antifungal potency.

Supplementary Materials

The following are available on line. 1H-NMR, 13C-NMR and mass spectroscopy (MS) of compounds 5a–m and 6a–m.

Author Contributions

J.-M.G. and A.-L.Z. designed and observed the proposal and contributed to data analysis and interpretation. B.L. performed the experiments and conducted the biological study. D.L. performed the molecular docking studies and wrote the molecular docking sections of the paper. B.L. wrote the manuscript. J.-M.G. and D.L. revised the manuscript. All authors discussed the results and implications, and commented on the manuscript at all stages.

Funding

This work was supported by the grants from the National Natural Science Foundation of China (No. 21502152, 21372185, 31371958), the Program of UnifiedPlanning Innovation Engineering of Science & Technology in Shaanxi Province (No. 2015KTCQ02-14), Chinese Universities Scientific Fund (No. 2452016092), and the Natural Science Foundation of Shaanxi Province (No. 2014JQ2075).

Acknowledgments

We would like to thank Ji-Jun Chen for measurement of HRMS of new compounds.

Conflicts of Interest

The authors declare no competing financial interest.

References

  1. Xiao, J.; Zhang, Q.; Gao, Y.Q.; Tang, J.J.; Zhang, A.L.; Gao, J.-M. Secondary metabolites from the endophytic Botryosphaeria dothidea of Melia azedarach and their antifungal, antibacterial, antioxidant, and cytotoxic activities. J. Agric. Food Chem. 2014, 62, 3584–3590. [Google Scholar] [PubMed]
  2. Meepagala, K.M.; Kuhajek, J.M.; Sturtz, G.D.; Wedge, D.E.; Vulgarone, B. The antifungal constituent in the steam-distilled fraction of Artemisia douglasiana. J. Chem. Ecol. 2003, 29, 1771–1780. [Google Scholar] [PubMed]
  3. Pérez-García, A.; Romero, D.; de Vicente, A. Plant protection and growth stimulation by microorganisms: Biotechnological applications of Bacilli in agriculture. Curr. Opin. Biotechnol. 2011, 22, 187–193. [Google Scholar] [CrossRef] [PubMed]
  4. Muto, M.; Takahashi, H.; Ishihara, K.; Yuasa, H.; Huang, J.W. Antimicrobial activity of medicinal plant extracts used by indigenous people in Taiwan. Plant. Pathol. Bull. 2005, 14, 13–24. [Google Scholar]
  5. Noolvi, M.N.; Patel, H.M.; Kaur, M. Benzothiazoles: Search for anticancer agents. Eur. J. Med. Chem. 2012, 54, 447–462. [Google Scholar] [CrossRef] [PubMed]
  6. Hutchinson, I.; Jennings, S.A.; Vishnuvajjala, B.R.; Westwell, A.D.; Stevens, M.F. Antitumor benzothizoles 16. Synthesis and pharmaceutical properties of antitumor 2(4-aminophenyl)benzothizoles amino acid prodrugs. J. Med. Chem 2002, 45, 744–747. [Google Scholar] [PubMed]
  7. Jiang, L.L.; Zuo, Y.; Wang, Z.F.; Tan, Y.; Wu, Q.Y.; Xi, Z.; Yang, G.F. Design and syntheses of novel N-(benzothiazol-5-yl)-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione and N-(benzothiazol-5-yl)isoindoline-1,3-dione as potent protoporphyrinogen oxidase inhibitors. J. Agric. Food Chem. 2011, 59, 6172–6179. [Google Scholar] [CrossRef] [PubMed]
  8. Burger, A.; Sawhney, S.N. Antimalarials III. Benzothiazole amino alcohols. J. Med. Chem. 1968, 11, 270–273. [Google Scholar] [CrossRef] [PubMed]
  9. Musser, J.H.; Kubrak, D.M.; Chang, J.; DiZio, S.M.; Hite, M.; Hand, J.M.; Lewis, A.J. Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters. J. Med. Chem. 1987, 30, 400–405. [Google Scholar] [PubMed]
  10. Sheng, C.; Xu, H.; Wang, W.; Cao, Y.; Dong, G.; Wang, S.; Che, X.; Ji, H.; Miao, Z.; Yao, J.; Zhang, W. Design, synthesis and antifung al activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors. Eur. J. Med. Chem. 2010, 45, 3531–3540. [Google Scholar] [CrossRef] [PubMed]
  11. Saeed, S.; Rashid, N.; Jones, P.G.; Ali, M.; Hussain, R. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. Eur. J. Med. Chem. 2010, 45, 1323–1331. [Google Scholar] [CrossRef] [PubMed]
  12. Kakkar, S.; Tahlan, S.; Lim, S.M.; Ramasamy, K.; Mani, V.; Shah, S.A.A.; Narasimhan, B. Benzoxazole derivatives: Design, synthesis and biological evaluation. Chem. Cent. J. 2018, 12, 92. [Google Scholar] [CrossRef] [PubMed]
  13. Li, D.; Luong, T.T.M.; Dan, W.-J.; Ren, Y.; Nien, H.X.; Zhang, A.-L.; Gao, J.-M. Natural products as sources of new fungicides (IV): Synthesis and biological evaluation of isobutyrophenone analogs as potential inhibitors of class-II fructose-1,6-bisphosphate aldolase. Bioorgan. Med. Chem. 2018, 26, 386–393. [Google Scholar] [CrossRef] [PubMed]
  14. Shi, W.; Dan, W.-J.; Tang, J.-J.; Zhang, Y.; Nandinsuren, T.; Zhang, A.-L.; Gao, J.-M. Natural products as sources of new fungicides (III): Antifungal activity of 2,4-dihydroxy-5-methylacetophenone derivatives. Bioorg. Med. Chem. Lett. 2016, 26, 2156–2158. [Google Scholar] [CrossRef] [PubMed]
  15. Kosaka, T.; Wakabayashi, T. Synthesis of 2-(4-aryl-1E,3E-butadienyl) benzoxazoleby the horner-wadsworth-emmons reaction. Heterocycles 1995, 41, 477–485. [Google Scholar] [CrossRef]
  16. Burkholder, C.R.; Dolbier, W.R., Jr.; Médebielle, M. Synthesis and reactivity of halogeno-difluoromethyl aromatics and heterocycles: Application to the synthesis of gem-difluorinated bioactive compounds. J. Fluorine Chem. 2001, 109, 39–48. [Google Scholar] [CrossRef]
  17. Zhao, C.; Ma, S. Recent Advances in The Discovery of N-Myristoyltransferase Inhibitors. ChemMedChem 2014, 9, 2425–2437. [Google Scholar] [CrossRef] [PubMed]
  18. Popp, F.D.; McEwen, W.E. Polyphosphoric acids as a reagent in organic chemistry. Chem. Rev. 1958, 58, 321–401. [Google Scholar] [CrossRef]
  19. So, Y.H.; Heeschen, J.P. Mechanism of polyphosphoric acid and phosphorus pentoxide–methanesulfonic acid as synthetic reagents for benzoxazole formation. J. Org. Chem. 1997, 62, 3552–3561. [Google Scholar] [CrossRef]
  20. Sheng, C.; Che, X.; Wang, W.; Wang, S.; Cao, Y.; Yao, J.; Miao, Z.; Zhang, W. Design and synthesis of antifungal benzoheterocyclic derivatives by scaffold hopping. Eur. J. Med. Chem. 2011, 46, 1706–1712. [Google Scholar] [CrossRef] [PubMed]
  21. Peprah, K.; Zhu, X.Y.; Eyunni, S.V.; Etukala, J.R.; Setola, V.; Roth, B.L.; Ablordeppey, S.Y. Structure–activity relationship studies of SYA 013, a homopiperazine analog of haloperidol. Bioorg. Med. Chem. 2012, 20, 1671–1678. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Hou, J.; Li, Z.; Fang, Q.; Feng, C.; Zhang, H.; Guo, W.; Wang, H.; Gu, G.; Tian, Y.; Liu, P.; et al. Discovery and extensive in vitro evaluations of NK-HDAC-1: A chiral histone deacetylase inhibitor as a promising lead. J. Med. Chem. 2012, 55, 3066–3075. [Google Scholar] [CrossRef] [PubMed]
  23. Hori, M.; Kataoka, T. Studies on benzothiazoline derivatives. III. Reactions of 2,2-disubstituted benzothiazolines with haloacyl halides or acid anhydrides. Chem. Pharm. Bull. 1979, 27, 1973–1981. [Google Scholar] [CrossRef]
  24. Sharghi, H.; Asemani, O. Methanesulfonic Acid/SiO2 as an efficient combination for the synthesis of 2-substituted aromatic and aliphatic benzothiazoles from carboxylic acids. Synth. Commun. 2009, 39, 860–867. [Google Scholar] [CrossRef]
  25. Morais, G.R.; Miranda, H.V.; Santos, I.C.; Santos, I; Outeiro, T.F.; Paulo, A. Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes. Bioorg. Med. Chem. 2011, 19, 7698–7710. [Google Scholar] [CrossRef] [PubMed]
  26. Njoya, Y.; Gellis, A.; Crozet, M.P.; Vanelle, P. Efficient synthesis of new 6-nitrobenzothiazoles using microwave irradiation. Sulfur Lett. 2003, 26, 67–75. [Google Scholar] [CrossRef]
  27. Gellis, A.; Boufatah, N.; Vanelle, P. Rapid microwave-promoted synthesis of new sulfonylmethylbenzothiazoles in water. Green Chem. 2006, 8, 483–487. [Google Scholar] [CrossRef]
  28. Lee, A.; Lee, K.; Kim, D. Using reverse docking for target identification and its applications for drug discovery. Expert Opin. Drug Dis. 2016, 11, 707–715. [Google Scholar] [CrossRef] [PubMed]
  29. Nile, A.H.; Tripathi, A.; Yuan, P.; Mousley, C.J.; Suresh, S.; Wallace, I.M.; Shah, S.D.; Pohlhaus, D.T.; Temple, B.; Nislow, C.; et al. PITPs as targets for selectively interfering with phosphoinositide signaling in cells. Nat. Chem. Biol. 2013, 10, 76. [Google Scholar] [CrossRef] [PubMed]
  30. Pries, V.; Nöcker, C.; Khan, D.; Johnen, P.; Hong, Z.; Tripathi, A.; Keller, A.-L.; Fitz, M.; Perruccio, F.; Filipuzzi, I.; et al. Target Identification and Mechanism of Action of Picolinamide and Benzamide Chemotypes with Antifungal Properties. Cell. Chem. Biol. 2018, 25, 279–290. [Google Scholar] [CrossRef] [PubMed]
  31. Filipuzzi, I.; Cotesta, S.; Perruccio, F.; Knapp, B.; Fu, Y.; Studer, C.; Pries, V.; Riedl, R.; Helliwell, S.B.; Petrovic, K.T.; et al. High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines. PLoS Genet. 2016, 12. [Google Scholar] [CrossRef] [PubMed]
  32. Nandinsuren, T.; Shi, W.; Zhang, A.L.; Bai, Y.B.; Gao, J.-M. Natural products as sources of new fungicides (II): Antiphytopathogenic activity of 2,4-dihydroxyphenyl ethanone derivatives. Nat. Prod. Res. 2016, 30, 1166–1169. [Google Scholar] [CrossRef] [PubMed]
  33. Xiao, J.; Zhang, Q.; Gao, Y.-Q.; Shi, X.-W.; Gao, J.-M. Antifungal and antibacterial metabolites from an endophytic Aspergillus sp. associated with Melia azedarach. Nat. Prod. Res. 2014, 28, 1388–1392. [Google Scholar] [CrossRef] [PubMed]
  34. Li, X.-J.; Zhang, Q.; Zhang, A.-L.; Gao, J.-M. Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities. J. Agric. Food Chem. 2012, 60, 3424–3431. [Google Scholar] [CrossRef] [PubMed]
  35. Li, D.; Chi, B.; Wang, W.-W.; Gao, J.-M.; Wan, J. Exploring the possible binding mode of trisubstituted benzimidazoles analogues in silico for novel drug designtargeting Mtb FtsZ. Med. Chem. Res. 2017, 26, 153–169. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds the benzoxazole and benzothiazole derivatives are available from the authors.
Molecules 23 02457 g001 550
Figure 1. Chemical structures of some drugs bearing benzoxazole and benzothiazole scaffolds.
Figure 1. Chemical structures of some drugs bearing benzoxazole and benzothiazole scaffolds.
Molecules 23 02457 g001
Molecules 23 02457 g002 550
Figure 2. Chemical structures of the antifungal compounds bearing benzoxazole and benzothiazole scaffolds.
Figure 2. Chemical structures of the antifungal compounds bearing benzoxazole and benzothiazole scaffolds.
Molecules 23 02457 g002
Molecules 23 02457 sch001 550
Scheme 1. Synthetic routes for 2-(Aryloxymethyl)-benzoxazole and -benzothiazole derivatives.
Scheme 1. Synthetic routes for 2-(Aryloxymethyl)-benzoxazole and -benzothiazole derivatives.
Molecules 23 02457 sch001
Molecules 23 02457 g003 550
Figure 3. Structure activity relationship of the synthesized compounds.
Figure 3. Structure activity relationship of the synthesized compounds.
Molecules 23 02457 g003
Molecules 23 02457 g004 550
Figure 4. The binding models of the test compounds into the lipid binding pocket of Sec14p from S. cerevisiae. (A) Superposition of PIA (yellow) and BEA (orange) in docking resultant models with PIA in the X-ray crystallographic structure (PDB 6F0E; gray). (B) Overlay of the six test benzoxazole and benzothiazole derivatives. (C–H) The binding modes of the compounds (in stick model with carbon) into the active site of Sec14p: (C) 5a (aquamarine); (D) 5b (orchid); (E) 5h (light green); (F) 5i (coral); (G) 5j (light gray); and (H) 6h (hot pink).
Figure 4. The binding models of the test compounds into the lipid binding pocket of Sec14p from S. cerevisiae. (A) Superposition of PIA (yellow) and BEA (orange) in docking resultant models with PIA in the X-ray crystallographic structure (PDB 6F0E; gray). (B) Overlay of the six test benzoxazole and benzothiazole derivatives. (C–H) The binding modes of the compounds (in stick model with carbon) into the active site of Sec14p: (C) 5a (aquamarine); (D) 5b (orchid); (E) 5h (light green); (F) 5i (coral); (G) 5j (light gray); and (H) 6h (hot pink).
Molecules 23 02457 g004
Table
Table 1. Preliminary Antifungal Activities of Compounds at 100 μg/mL a.
Table 1. Preliminary Antifungal Activities of Compounds at 100 μg/mL a.
Cpd.Average Values of Inhibition Rate (%) to Eight Pathogens
F. n.F. g.F. s.A. s.C. g.V. m.M. o.B. c.
5a85871009210010095100
5b5130856970437280
5c4430415737394468
5d3845433457443878
5e4438413733462533
5f2834574349494462
5g2630475745365361
5h6230896956805572
5i5930876361908179
5j3949784357535033
5k182423925201944
5l3340232945293439
5m3527585647725058
6a3556493647363993
6b2830342629362536
6c2132283457197267
6d1632511635433445
6e331828522381622
6f8302391812633
6g32032314536211
6h3971692881464452
6i2024193232162552
6j18282391892028
6k114341626222459
6l3128344625122581
6m1656502032364859
Hy697188632016100100
a Note: F. n., Fusarium oxysporum f. sp. niveum; F. g., Fusarium graminearum; F. s., Fusarium solani; A. s., Alternaria solani; C. g., Colletotrichum gloeosporioides; V. m., Valsa mali; M. o., Magnaporthe oryzae; B. c., Botrytis cinerea; and Hy, hymexazol.
Table
Table 2. IC50 values of Some Compounds on Eight Phytopathogenic Fungi a.
Table 2. IC50 values of Some Compounds on Eight Phytopathogenic Fungi a.
Cpd.IC50 ± SD/(μg/mL)
F. n.F. g.F. s.A. s.C. g.V. m.M. o.B. c.
5a45.00 ± 2.7120.59 ± 2.3412.27 ± 0.8823.23 ± 1.5825.94 ± 2.5323.52 ± 1.6365.25 ± 2.9819.92 ± 3.34
5b>100>10015.98 ± 1.1532.10 ± 7.1132.78 ± 2.11>10030.61 ± 0.7323.78 ± 1.55
5c>100>100>100>100>100>100>10050.04 ± 6.03
5f>100>100>100>100>100>100>10073.04 ± 3.54
5g>100>100>100>100>100>100>10077.41 ± 3.16
5h94.48 ± 2.28>1004.34 ± 0.1333.32 ± 2.82>10031.34 ± 2.64>10035.52 ± 2.95
5i>100>10017.61 ± 0.9373.09 ± 4.1083.35 ± 1.0437.98 ± 2.7573.62 ± 5.1242.01 ± 2.76
5j>100>10016.53 ± 1.89>100>100>100>100>100
5m>100>100>100>100>10059.65 ± 5.0>100>100
6a>100>100>100>100>100>100>10062.62 ± 2.17
6c>100>100>100>100>100>100>10061.20 ± 4.91
6h>10023.39 ± 1.2915.55 ± 1.35>10029.61 ± 1.39>100>100>100
6l>100>100>100>100>100>100>10050.42 ± 5.75
Hy8.47 ± 1.7259.93 ± 2.1938.92 ± 3.1754.16 ± 1.46>100>15035.40 ± 2.384.72 ± 0.52
a Note: The results were expressed as the mean ± SD of triplicate experiments.
Table
Table 3. The docking results of the tested compounds.
Table 3. The docking results of the tested compounds.
Cpd.Binding Energy (kcal/mol)Inhibit Constant (μM)
5a−6.898.92
5b−6.869.39
5h−7.383.9
5i−7.662.44
5j−7.851.78
6h−7.762.06
PIA a−6.967.97 (9.4) c
BEA b−7.542.99 (1.7) c
a The inhibitor co-crystals with Sec14p from S. cerevisiae in the crystal structure of the protein complex (PDB code: 6F0E). b The benzamide compound 2 in the reference. c The value in parenthesis are IC50 for the active compound against Sec14p from S. cerevisiae.

Share and Cite

MDPI and ACS Style

Luo, B.; Li, D.; Zhang, A.-L.; Gao, J.-M. Synthesis, Antifungal Activities and Molecular Docking Studies of Benzoxazole and Benzothiazole Derivatives. Molecules 2018, 23, 2457. https://doi.org/10.3390/molecules23102457

AMA Style

Luo B, Li D, Zhang A-L, Gao J-M. Synthesis, Antifungal Activities and Molecular Docking Studies of Benzoxazole and Benzothiazole Derivatives. Molecules. 2018; 23(10):2457. https://doi.org/10.3390/molecules23102457

Chicago/Turabian Style

Luo, Bo, Ding Li, An-Ling Zhang, and Jin-Ming Gao. 2018. "Synthesis, Antifungal Activities and Molecular Docking Studies of Benzoxazole and Benzothiazole Derivatives" Molecules 23, no. 10: 2457. https://doi.org/10.3390/molecules23102457

Article Metrics

Back to TopTop